The GLP is committed to full transparency. Download and review our Annual Report.

Plaintiffs may struggle to prove Roundup causes cancer in upcoming glyphosate trials

| | January 10, 2019

Bayer’s Monsanto is facing thousands of lawsuits from plaintiffs claiming exposure to glyphosate gave them cancer. Last August, a jury handed Dewayne Johnson a huge victory when it awarded him millions of dollars for his claims. The verdict was perplexing because all the independent evidence available disproves a link between the herbicide and cancer.

But the next trial will be different.

U.S. District Judge Vince Chhabria granted Monsanto’s motion to bifurcate the trial. That is, he agreed to split the trial into two phases. Plaintiff Edward Hardeman will first need to prove that glyphosate causes cancer. Only then will he be allowed to present evidence that Monsanto tried to interfere with regulations and intimidate scientists.

Related article:  EPA reaffirms glyphosate weed killer safe, calls IARC cancer designation an 'outlier' inconsistent with multiple assessments

It’s incredibly likely that Johnson’s jury was swayed by….Monsanto’s alleged misconduct. Hardeman’s attorneys have presented that same evidence to Judge Chhabria. And Judge Chhabria realized the statements were taken out of context and distorted….So he’s making Hardeman prove the most important part of his claim first: the science.

Read full, original article: Federal Judge Agrees to Limit Evidence in the Next Round-Up Trial

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend